JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms

American Journal of Hematology

Volumn 87, Issue 7, 2012, Pages 746-747

  Pietra, Daniela ^a   Casetti, Ilaria ^a   Da Vià, Matteo C ^a   Elena, Chiara ^a   Milanesi, Chiara ^a   Rumi, Elisa ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; JANUS KINASE 2; MPL PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ALLELE; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LETTER; MAJOR CLINICAL STUDY; MYELOPROLIFERATIVE NEOPLASM; PRIORITY JOURNAL; SOMATIC MUTATION; T LYMPHOCYTE;

ALLELES; AMINO ACID SUBSTITUTION; COHORT STUDIES; EXONS; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; ITALY; JANUS KINASE 2; MUTATION; MYELOPROLIFERATIVE DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRIMARY MYELOFIBROSIS; RECEPTORS, THROMBOPOIETIN; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84862536815     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23229     Document Type: Letter

References (10)

1. Jones AV, Chase A, Silver RT, et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 2009; 41: 446-449.
2. Olcaydu D, Harutyunyan A, Jager R, et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet 2009; 41: 450-454.
3. Kilpivaara O, Mukherjee S, Schram AM, et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet 2009; 41: 455-459.
4. Olcaydu D, Skoda RC, Looser R, et al. The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia 2009; 23: 1924-1926.
5. Beer PA, Campbell PJ, Scott LM, et al. MPL mutations in myeloproliferative disorders: Analysis of the PT-1 cohort. Blood 2008; 112: 141-149.
6. Boyd EM, Bench AJ, Goday-Fernandez A, et al. Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis. Br J Hematol 2010; 149: 250-257.
7. Pietra D, Brisci A, Rumi E, et al. Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms. Hematologica 2011; 96: 607-611.
8. Pardanani A, Lasho TL, Finke CM, et al. Infrequent occurrence of MPL exon 10 mutations in polycythemia vera and post-polycythemia vera myelofibrosis. Am J Hematol 2011; 86: 701-702.
9. Jones AV, Campbell PJ, Beer PA, et al. The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms. Blood 2010; 115: 4517-4523.
10. Patnaik MM, Lasho TL, Finke CM, et al. MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms. Leukemia 2010; 24: 859-860.